Medicated chest rubs recalled for improper storage temperature conditions
Vicks VapoRub and Swan Medicated Chest Rub products from Family Dollar Stores are being recalled due to improper storage temperature conditions during their distribution.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall for Current Good Manufacturing Practice deviations related to improper storage temperature conditions. The hazard relates to product handling and storage practices during distribution rather than inherent product safety issues.
Plain-English summary
Vicks VapoRub 1.76 oz (SKU 919667), Vicks VapoRub Lavender 1.76 oz (SKU 999813), and Swan Medicated Chest Rub 3.53 oz (SKU 920611) are subject to this recall. These products were distributed to specific Family Dollar Stores nationwide.
The products are being recalled due to Current Good Manufacturing Practice (CGMP) deviations. Specifically, the products were held outside appropriate storage temperature conditions during distribution, which may affect product quality.
The products were distributed from April 30, 2022 through June 10, 2022. Consumers who purchased these products should verify them by the SKU numbers listed on the packaging.
If you have any of these products, consult with a healthcare provider or contact Family Dollar Stores for guidance on how to proceed.
The recalled product
- Product
- VICKS VAPORUB 1.76 OZ SKU 919667 VICKS VAPOR RUB LAVENDER 1.76 OZ 999813 SWAN MEDICATED CHEST RUB 3.53 OZ SKU 920611 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Over-the-Counter Topical
- Hazard
- cgmp-violation
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- SKUs: 919667
- 999813
- 920611
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27